Description
CJC-1295 (Without DAC) 5mg – Research Peptide
CJC-1295 (Without DAC) 5mg is a high-purity, research-grade synthetic peptide supplied for controlled laboratory investigation involving growth hormone–related signaling pathways, peptide-receptor interactions, and endocrine system research.
CJC-1295 without DAC is a modified analog of growth hormone–releasing hormone (GHRH 1–29). Peptides of this class are referenced in scientific literature examining molecular pathways associated with pituitary signaling and growth hormone regulatory systems.
The non-DAC formulation represents a short-duration variant of CJC-1295 commonly referenced in laboratory models examining peptide activity over shorter observation windows.
CJC-1295 (Without DAC) 5mg is supplied strictly for in-vitro laboratory research and analytical investigation. This compound is not approved for human or veterinary use.
What Is CJC-1295 (Without DAC)?
CJC-1295 (No DAC) is a synthetic peptide structurally related to fragments of endogenous growth hormone–releasing hormone (GHRH).
In scientific literature, GHRH analogues have been examined in experimental models involving endocrine signaling pathways and pituitary receptor interactions.
Research discussions referencing CJC-1295 and related peptides have examined topics including:
• Growth hormone–associated signaling pathways
• Pituitary receptor interaction models
• IGF-1 related molecular signaling systems
• Endocrine communication pathways
• Circadian hormone signaling research
These areas remain subjects of ongoing experimental investigation.
Areas of Scientific Investigation
Research literature referencing CJC-1295 and related GHRH analogues has examined laboratory models involving:
• Growth hormone signaling pathway analysis
• Pituitary receptor binding studies
• IGF-1 related molecular pathway research
• Endocrine system signaling investigations
• Circadian rhythm models involving hormone signaling
These references are provided for informational context regarding the compound’s presence in scientific research.
Laboratory Research Contexts
Researchers may investigate CJC-1295 (Without DAC) within experimental frameworks such as:
• Peptide-receptor interaction studies
• Endocrine signaling pathway analysis
• Pituitary signaling research models
• Molecular pathway investigations involving GHRH analogues
• Peptide structure and stability studies
CJC-1295 (Without DAC) 5mg – Research Supply Specifications
• Synthetic research peptide
• 5mg lyophilized peptide per vial
• Analytical purity standard: 99%+
• Third-party laboratory testing for identity and purity
• Manufactured under controlled quality standards
• Canada-based fulfillment
• Batch-level quality verification
Purity & Quality Assurance
ExoLabz supplies research peptides manufactured to high analytical standards. Each batch of CJC-1295 (Without DAC) undergoes independent third-party testing to verify peptide identity and purity.
Researchers may perform additional analytical verification if required for laboratory use. If validated testing confirms a verified purity discrepancy, ExoLabz provides refund and testing reimbursement in accordance with company policy.
Important Legal Notice
For Research Purposes Only
CJC-1295 (Without DAC) 5mg is supplied strictly for laboratory research and analytical use.
This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications.
This product has not been evaluated or approved by Health Canada, the U.S. Food and Drug Administration (FDA), or any other regulatory authority.
By purchasing this product, the buyer confirms that the material will be handled only by qualified professionals and used solely for lawful laboratory research purposes.
